COVID-19 dynamics after a national immunization program in Israel.

Area of Science:

• * Public Health
• * Vaccinology
• * Epidemiology

Background:

• * The BNT162b2 vaccine (Pfizer-BioNTech) was developed for Coronavirus Disease 2019 (COVID-19) prevention.
• * Real-world effectiveness data are crucial for assessing public health interventions.

Purpose of the Study:

• * To evaluate the real-life impact of the BNT162b2 vaccine on COVID-19 incidence and hospitalizations.
• * To analyze the temporal relationship between vaccination rollout and pandemic dynamics in Israel.

Main Methods:

• * Retrospective analysis of Israeli Ministry of Health data (August 2020 - February 2021).
• * Comparison of COVID-19 trends between age groups, lockdown periods, and early vs. late-vaccinated cities.
• * Statistical analysis to differentiate vaccine effects from confounding factors like lockdowns.

Main Results:

• * Significant and earlier reduction in COVID-19 cases and hospitalizations observed in prioritized older adults (≥60 years).
• * Subsequent decreases noted in younger age groups, correlating with vaccination order.
• * Observed patterns were more pronounced in early-vaccinated cities and distinct from previous lockdown effects.

Conclusions:

• * The BNT162b2 vaccination campaign demonstrated a clear real-world effect on reducing COVID-19 burden.
• * Vaccine prioritization by age and geographical rollout timing influenced pandemic control outcomes.